Informative Tools to Optimize Neoadjuvant Therapy in ER Positive, HER2 Negative Breast Cancers
Clinical trial NCT03790813 · UNKNOWN
Trial details
- NCT number
- NCT03790813
- Sponsor
- British Columbia Cancer Agency
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2019-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.